申请人:Takeda Chemical Industries, Ltd.
公开号:US05457106A1
公开(公告)日:1995-10-10
There is disclosed a pharmaceutical composition for providing antiinflammatory, antipyretic, analgesic, antiallergic, immunosuppressing or immunomodulating activity which comprises a pyridine derivative of the formula (I): ##STR1## wherein R is an optionally substituted pyridine ring, X is a oxygen atom or --S(O).sub.n --, wherein n is 0, 1 or 2, A is a bivalent C.sub.1-15 hydrocarbon residue whose branched moiety may have a substituent, Y is an oxygen or sulfur atom, R.sub.3 is a hydrogen atom or an optionally substituted hydrocarbon residue, R.sub.4 is an optionally substituted hydrocarbon residue or an optionally substituted monocyclic or bicyclic heterocyclic group, R.sub.3 and R.sub.4 may be joined together with the carbamoyl group or the thiocarbamoyl group to which they are attached to form an optionally substituted heterocyclic group, or R.sub.3 or R.sub.4 may be independently attached to A to form a ring, or a pharmaceutically acceptable salt or solvate thereof, and a pharmaceutically acceptable carrier or diluent.
本发明涉及一种药物组合物,用于提供抗炎、退热、止痛、抗过敏、免疫抑制或免疫调节活性,其包括公式(I)的吡啶衍生物:##STR1## 其中R是可选择性取代的吡啶环,X是氧原子或--S(O).sub.n --,其中n为0、1或2,A是双价的C.sub.1-15烃基残基,其分支部分可以有取代基,Y是氧或硫原子,R.sub.3是氢原子或可选择性取代的碳氢基残基,R.sub.4是可选择性取代的碳氢基残基或可选择性取代的单环或双环杂环基团,R.sub.3和R.sub.4可以与它们附着的碳酰胺基团或硫代碳酰胺基团结合在一起形成可选择性取代的杂环基团,或者R.sub.3或R.sub.4可以独立地附着在A上形成一个环,或其药学上可接受的盐或溶剂,以及药学上可接受的载体或稀释剂。